Atsushi Kuwahara
Atsushi Kuwahara publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Biomedical Engineering, on topics such as Retinal Development and Disorders, Neuroscience and Neural Engineering and Pluripotent Stem Cells Research.
- World rank
- #984,417 of 7,710,434 ranked researchers
- Rank in Japan
- #13,151 of 383,136
- Works
- 54
- Citations
- 2.3k
- Citations per work
- 42.1
What does Atsushi Kuwahara research?
Atsushi Kuwahara's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Neuroscience (14%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2852.6%
- Everything else1732.4%
- Health Sciences510.0%
- Medicine510.0%
- Physical Sciences35.0%
- Engineering35.0%
- 1Molecular Biology35% of their works
- 2Cellular and Molecular Neuroscience14% of their works
- 3Biomedical Engineering5% of their works
- 4Pharmacology5% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Toxicology4% of their works
Research topics
- Retinal Development and Disorders
- Neuroscience and Neural Engineering
- Pluripotent Stem Cells Research
- Analytical chemistry methods development
- Microbial Natural Products and Biosynthesis
- Protein purification and stability
- Photoreceptor and optogenetics research
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Atsushi Kuwahara's research?
The keywords of their largest research topics: Gene Therapy, Retinitis Pigmentosa, Electrode Arrays, Neural Stimulation, Induced Pluripotent Stem Cells, Monoclonal Antibodies, Pluripotent Stem Cells and Therapeutic Antibodies.
- Protein Aggregation
- Fc Receptors
- Biopharmaceuticals
- Solid-Phase Microextraction
- Molecularly Imprinted Polymers
- Therapeutic Antibodies
- Monoclonal Antibodies
- Neural Stimulation
- Retinitis Pigmentosa
- Gene Therapy
- Electrode Arrays
- Induced Pluripotent Stem Cells
- Pluripotent Stem Cells
- Drug Discovery
- Natural Products
- Antibody Engineering
- Channelrhodopsin
- Optogenetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Gene Therapy181 topic
- Retinitis Pigmentosa181 topic
- Electrode Arrays121 topic
- Neural Stimulation121 topic
- Induced Pluripotent Stem Cells81 topic
- Monoclonal Antibodies82 topics
- Pluripotent Stem Cells81 topic
- Therapeutic Antibodies82 topics
- Drug Discovery51 topic
- Molecularly Imprinted Polymers51 topic
- Natural Products51 topic
- Solid-Phase Microextraction51 topic
- Antibody Engineering41 topic
- Biopharmaceuticals41 topic
- Channelrhodopsin41 topic
- Fc Receptors41 topic
- Optogenetics41 topic
- Protein Aggregation41 topic
Where does Atsushi Kuwahara work?
Atsushi Kuwahara's main affiliation in the publication record is Sumitomo Dainippon Pharma (Japan), Japan.
How many publications and citations does Atsushi Kuwahara have?
OpenAlex counts 54 works and 2,272 citations for Atsushi Kuwahara, an h-index of 21, ranking #984,417 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Atsushi Kuwahara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.